Abstract

Despite the uniform mortality in pancreatic adenocarcinoma (PDAC), clinical disease heterogeneity exists with limited genomic differences. A highly aggressive tumor subtype termed ‘basal-like’ was identified to show worse outcomes and higher inflammatory responses. Here, we focus on the microbial effect in PDAC progression and present a comprehensive analysis of the tumor microbiome in different PDAC subtypes with resectable tumors using metagenomic sequencing. We found distinctive microbial communities in basal-like tumors and identified an increasing abundance of Acinetobacter, Pseudomonas and Sphingopyxis to be highly associated with carcinogenesis. Functional characterization of microbial genes suggested the potential to induce pathogen-related inflammation. Host-microbiota interplay analysis provided new insights into the tumorigenic role of specific microbiome compositions and demonstrated the influence of host genetics in shaping the tumor microbiome. Taken together, these findings indicated that the tumor microbiome is closely related to PDAC oncogenesis and the induction of inflammation. Additionally, our data revealed the microbial basis of PDAC heterogeneity and proved the predictive value of the microbiome, which will contribute to the intervention and treatment of disease.

Guo, Zhang, Guo et al. investigate microbiome alterations in different molecular subtypes of PDAC and report that distinct signatures exist in basal-like tumours, characterized by an increase in certain bacteria, such as Acinetobacter, Pseudomonas and Sphingopyxis. The authors associate increases in these bacteria with increased inflammation and carcinogenic potential, as suggested by pathway analyses.

Details

Title
Tumor microbiome contributes to an aggressive phenotype in the basal-like subtype of pancreatic cancer
Author
Guo, Wei 1   VIAFID ORCID Logo  ; Zhang, Yuchao 2 ; Guo Shiwei 3 ; Mei Zi 4 ; Liao Huiping 4 ; Dong Hang 4 ; Wu, Kai 4 ; Ye Haocheng 4 ; Zhang, Yuhang 4 ; Zhu, Yufei 4 ; Lang, Jingyu 4   VIAFID ORCID Logo  ; Hu Landian 4   VIAFID ORCID Logo  ; Jin, Gang 3   VIAFID ORCID Logo  ; Kong Xiangyin 1   VIAFID ORCID Logo 

 Chinese Academy of Sciences (CAS), Key Laboratory of Stem Cell Biology, Shanghai Jiao Tong University School of Medicine (SJTUSM) & Shanghai Institute of Nutrition and Health, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309); Chinese Academy of Sciences, CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309) 
 Chinese Academy of Sciences, CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309); Fudan University, School of Life Science, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443) 
 Changhai Hospital, Second Military Medical University, Department of General Surgery, Shanghai, China (GRID:grid.411525.6) (ISNI:0000 0004 0369 1599) 
 Chinese Academy of Sciences, CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Shanghai, China (GRID:grid.9227.e) (ISNI:0000000119573309) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2567801413
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.